Kyrgyzstan Vaccine Industry Outlook 2024 - 2028

See how Kyrgyzstan Vaccine performed compared to key markets.

Key Market Indicators

Kyrgyzstan's vaccination coverage for children aged one year is projected to maintain a stable rate, reaching 95% by 2028. This comes as no change from the current 95% coverage recorded in 2023. The vaccination coverage has shown a consistent increase of 0.6 percentage points annually since 1997. In contrast, Kyrgyzstan's vaccine imports are anticipated to decline. By 2028, imports are expected to fall to approximately $2.7 million, down from nearly $2.95 million in 2023. This represents an average annual decrease of 1.6% in vaccine imports. Since 2005, the country's demand for vaccines has been decreasing by an average of 0.5% per year. On the supply side, Kyrgyzstan has faced a significant downturn. Since 2017, the supply of vaccines has plummeted by 21% annually, highlighting ongoing challenges in maintaining adequate vaccine stocks.

Kyrgyzstan Vaccine Market Data and Forecasts

How much will Kyrgyzstan Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Kyrgyzstan
Forecast: Import of Vaccines for Human Use to Kyrgyzstan
Forecast: Measles-Containing-Vaccine Second-Dose (MCV2) Immunization Coverage in Kyrgyzstan

Other Top Countries about Vaccine